CD4 and HIV infectious disease: The introduction of HAART has led to very important declines in both mortality and morbidity due to HIV infection [2]; however, even though many patients steadily recover their CD4+ T cell compartment over several years post-HAART initiation, the degree of immune recovery achieved is highly variable.